Effects of different inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, pravastatin sodium and simvastatin, on sterol synthesis and immunological functions in human lymphocytes in vitro
- 31 August 1996
- journal article
- Published by Elsevier in Immunopharmacology
- Vol. 34 (1), 51-61
- https://doi.org/10.1016/0162-3109(96)00108-7
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Interferon-γ suppresses PDGF production from THP-1 cells and blood monocyte-derived macrophagesAtherosclerosis, 1992
- Tissue selectivity of pravastatin sodium, lovastatin and simvastatinEuropean Journal of Biochemistry, 1992
- Interferon-gamma inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages.JCI Insight, 1992
- Relative Lipophilicities, Solubilities, and Structure–Pharmacological Considerations of 3-Hydroxy-3-Methylglutaryl-Coenzyme A (HMG-CoA) Reductase Inhibitors Pravastatin, Lovastatin, Mevastatin, and SimvastatinJournal of Pharmaceutical Sciences, 1991
- Modulation of the immune response to tumors by a novel synthetic compound, (4R)-3-benzoyl-N-[(1R)-1-phenylethyl]-4-thiazolidinecarboxamide (RS-0481)Cancer Immunology, Immunotherapy, 1991
- Tissue-selective inhibition of cholesterol synthesis in vivo by pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitorBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990
- Identification of a new surface molecule expressed by human LGL and LAK cells: Production of a specific monoclonal antibody and comparison with other NK/LAK markersCellular Immunology, 1989
- Suppression of lymphoid cell function in vitro by inhibition of 3-hydroxy-3-methylglutaryl coenzyme a reductase by lovastatinInternational Journal of Immunopharmacology, 1989
- CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal speciesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1986
- ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogensis produced by Penicillium citrinum.The Journal of Antibiotics, 1976